Showing results (681-690 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. Gastroenterology & Hepatology|January 10, 2025
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trialBruce E Sands, Remo Panaccione, Geert D'Haens, et al.
Inflammatory Bowel Diseases|June 1, 2026
Ultrasound criteria for transmural healing and response in Crohn's disease: a systematic review of definitions and thresholdsJoëlle St-Pierre, Maxime Delisle, Yusuke Miyatani, et al.
ACS Chemical Biology|June 6, 2024
Development of Luminescent Biosensors for CalprotectinTong Lan, Tomasz Slezak, Jinyue Pu, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsDavid T Rubin, Iris Dotan, Aaron DuVall, et al.
Gastroenterology|August 13, 2022
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II StudyBaili Chen, Jie Zhong, Xiuling Li, et al.
Crohn'S & Colitis 360|February 13, 2023
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab ReintroductionInessa Normatov, Daniela Fluxa, Jingzhou D Wang, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.
The American Journal of Clinical Nutrition|June 10, 2016
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitisKatherine Meckel, Yan Chun Li, John Lim, et al.
Inflammatory Bowel Diseases|April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness PanelShane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Pageof 79